In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates
about
In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolatesAntifungal peptides: novel therapeutic compounds against emerging pathogensInhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compoundsCaspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcomeCorrelation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasisRandomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases.Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents.Molecular tracking of Candida albicans in a neonatal intensive care unit: long-term colonizations versus catheter-related infections.In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates.Caspofungin activity against clinical isolates of fluconazole-resistant Candida.In Vitro Activity of Caspofungin Against Fluconazole-Resistant Candida Species Isolated From Clinical Samples in Iran.
P2860
Q28345261-3A89FD48-8380-401E-9BA2-6FEBC5839E12Q28369443-059DD435-18B2-4E60-9EE8-4359980CFEE6Q28379616-F06D312D-451F-446A-9841-0844AE6915BDQ33935389-30BF12F6-BE68-4F75-9B37-5F94CC85A9A1Q33967543-17ABE02B-C641-4FF1-B727-2D22A63A7BFFQ34105475-2D4F619E-E6B7-4315-A527-6DA9D2D6B1A9Q34123805-2BC47B95-8D11-4B09-8EF7-B1C42AEE2751Q36547839-99110BEF-0EA6-4FFE-A7F7-C0E8CC373C53Q39731811-492A3D67-753A-474E-A42B-D4C15A8B575DQ40404311-58D8E3EC-1A8E-45AA-BAEF-DF3053B3E4AFQ41024436-EBF04EC0-2BFC-4F7A-9031-5E25324F4A89
P2860
In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates
description
1996 nî lūn-bûn
@nan
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
In vitro activities of semisyn ...... ible Candida albicans isolates
@ast
In vitro activities of semisyn ...... ible Candida albicans isolates
@en
In vitro activities of semisyn ...... ible Candida albicans isolates
@nl
type
label
In vitro activities of semisyn ...... ible Candida albicans isolates
@ast
In vitro activities of semisyn ...... ible Candida albicans isolates
@en
In vitro activities of semisyn ...... ible Candida albicans isolates
@nl
prefLabel
In vitro activities of semisyn ...... ible Candida albicans isolates
@ast
In vitro activities of semisyn ...... ible Candida albicans isolates
@en
In vitro activities of semisyn ...... ible Candida albicans isolates
@nl
P2860
P356
P1476
In vitro activities of semisyn ...... ible Candida albicans isolates
@en
P2093
Martinez-Suarez JV
Rodriguez-Tudela JL
P2860
P304
P356
10.1128/AAC.40.5.1277
P407
P577
1996-05-01T00:00:00Z